Imatinib (IM) in Combination with Hydroxyurea in Patients with CML1st CP Does Not Increase Molecular Response at 18 Months Compared to IM Alone. Final Results of the OSHO CML2004 Study. NCT 02480608
Onkologie（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined